Friday, July 7, 2017

Pharma shells out $2B-plus to doctors—again—with Allergan and Celgene in the lead

Despite some early predictions that transparency would change everything, drug and device makers' payments to doctors have remained remarkably consistent since the 2014 debut of the U.S. government's Open Payments database. All told, 631,000 doctors collected $2.8 billion in general payments in 2016, roughly the same as last year.
Post a Comment